DLAT and hepatocellular carcinoma: Although studies have reported that DLAT was associated with poor prognosis in HCC (Ke et al. 2023; Zhou et al. 2022), the underlying molecular mechanisms by which it regulates HCC progression through metabolic reprogramming remain obscure in HCC.